The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual

Research output: Contribution to journalReviewResearchpeer-review

Standard

The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual. / Wintner, Lisa M; Sztankay, Monika; Aaronson, Neil; Bottomley, Andrew; Giesinger, Johannes M; Groenvold, Mogens; Petersen, Morten Aa.; van de Poll-Franse, Lonneke; Velikova, Galina; Verdonck-de Leeuw, Irma; Holzner, Bernhard; EORTC Quality of Life Group.

In: European Journal of Cancer, Vol. 68, 11.2016, p. 73-81.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Wintner, LM, Sztankay, M, Aaronson, N, Bottomley, A, Giesinger, JM, Groenvold, M, Petersen, MA, van de Poll-Franse, L, Velikova, G, Verdonck-de Leeuw, I, Holzner, B & EORTC Quality of Life Group 2016, 'The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual', European Journal of Cancer, vol. 68, pp. 73-81. https://doi.org/10.1016/j.ejca.2016.08.024

APA

Wintner, L. M., Sztankay, M., Aaronson, N., Bottomley, A., Giesinger, J. M., Groenvold, M., Petersen, M. A., van de Poll-Franse, L., Velikova, G., Verdonck-de Leeuw, I., Holzner, B., & EORTC Quality of Life Group (2016). The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual. European Journal of Cancer, 68, 73-81. https://doi.org/10.1016/j.ejca.2016.08.024

Vancouver

Wintner LM, Sztankay M, Aaronson N, Bottomley A, Giesinger JM, Groenvold M et al. The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual. European Journal of Cancer. 2016 Nov;68:73-81. https://doi.org/10.1016/j.ejca.2016.08.024

Author

Wintner, Lisa M ; Sztankay, Monika ; Aaronson, Neil ; Bottomley, Andrew ; Giesinger, Johannes M ; Groenvold, Mogens ; Petersen, Morten Aa. ; van de Poll-Franse, Lonneke ; Velikova, Galina ; Verdonck-de Leeuw, Irma ; Holzner, Bernhard ; EORTC Quality of Life Group. / The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual. In: European Journal of Cancer. 2016 ; Vol. 68. pp. 73-81.

Bibtex

@article{4b1e73c83be94ff6a10846a871654198,
title = "The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual",
abstract = "Cancer has increasingly become a chronic condition and the routine collection of patient-reported outcomes (PROs) like quality of life is widely recommended for clinical practice. Nonetheless, the successful implementation of PROs is still a major challenge, although common barriers to and facilitators of their beneficial use are well known. To support health care professionals and other stakeholders in the implementation of the EORTC PRO measures, the EORTC Quality of Life Group provides guidance on issues considered important for their use in daily clinical practice. Herein, we present an outline of the newly developed {"}'Manual for the use of EORTC measures in daily clinical practice{"}, covering the following issues: * a rationale for using EORTC measures in routine care *selection of EORTC measures, timing of assessments, scoring and presentation of results * aspects of a strategic implementation * electronic data assessment and telemonitoring, and * further use of EORTC measures and ethical considerations. Next to an extensive overview of currently available literature, the manual specifically focuses on knowledge about EORTC measures to give evidence-based recommendations whenever possible and to encourage readers and end-users of EORTC measures to contribute to further needed high-quality research. The manual will be accessible on the EORTC Quality of Life Group website's homepage and will be periodically updated to take into account any new knowledge due to medical, technical, regulatory and scientific advances.",
author = "Wintner, {Lisa M} and Monika Sztankay and Neil Aaronson and Andrew Bottomley and Giesinger, {Johannes M} and Mogens Groenvold and Petersen, {Morten Aa.} and {van de Poll-Franse}, Lonneke and Galina Velikova and {Verdonck-de Leeuw}, Irma and Bernhard Holzner and {EORTC Quality of Life Group}",
note = "Copyright {\textcopyright} 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.",
year = "2016",
month = nov,
doi = "10.1016/j.ejca.2016.08.024",
language = "English",
volume = "68",
pages = "73--81",
journal = "European Journal of Cancer, Supplement",
issn = "0959-8049",
publisher = "Pergamon",

}

RIS

TY - JOUR

T1 - The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual

AU - Wintner, Lisa M

AU - Sztankay, Monika

AU - Aaronson, Neil

AU - Bottomley, Andrew

AU - Giesinger, Johannes M

AU - Groenvold, Mogens

AU - Petersen, Morten Aa.

AU - van de Poll-Franse, Lonneke

AU - Velikova, Galina

AU - Verdonck-de Leeuw, Irma

AU - Holzner, Bernhard

AU - EORTC Quality of Life Group

N1 - Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

PY - 2016/11

Y1 - 2016/11

N2 - Cancer has increasingly become a chronic condition and the routine collection of patient-reported outcomes (PROs) like quality of life is widely recommended for clinical practice. Nonetheless, the successful implementation of PROs is still a major challenge, although common barriers to and facilitators of their beneficial use are well known. To support health care professionals and other stakeholders in the implementation of the EORTC PRO measures, the EORTC Quality of Life Group provides guidance on issues considered important for their use in daily clinical practice. Herein, we present an outline of the newly developed "'Manual for the use of EORTC measures in daily clinical practice", covering the following issues: * a rationale for using EORTC measures in routine care *selection of EORTC measures, timing of assessments, scoring and presentation of results * aspects of a strategic implementation * electronic data assessment and telemonitoring, and * further use of EORTC measures and ethical considerations. Next to an extensive overview of currently available literature, the manual specifically focuses on knowledge about EORTC measures to give evidence-based recommendations whenever possible and to encourage readers and end-users of EORTC measures to contribute to further needed high-quality research. The manual will be accessible on the EORTC Quality of Life Group website's homepage and will be periodically updated to take into account any new knowledge due to medical, technical, regulatory and scientific advances.

AB - Cancer has increasingly become a chronic condition and the routine collection of patient-reported outcomes (PROs) like quality of life is widely recommended for clinical practice. Nonetheless, the successful implementation of PROs is still a major challenge, although common barriers to and facilitators of their beneficial use are well known. To support health care professionals and other stakeholders in the implementation of the EORTC PRO measures, the EORTC Quality of Life Group provides guidance on issues considered important for their use in daily clinical practice. Herein, we present an outline of the newly developed "'Manual for the use of EORTC measures in daily clinical practice", covering the following issues: * a rationale for using EORTC measures in routine care *selection of EORTC measures, timing of assessments, scoring and presentation of results * aspects of a strategic implementation * electronic data assessment and telemonitoring, and * further use of EORTC measures and ethical considerations. Next to an extensive overview of currently available literature, the manual specifically focuses on knowledge about EORTC measures to give evidence-based recommendations whenever possible and to encourage readers and end-users of EORTC measures to contribute to further needed high-quality research. The manual will be accessible on the EORTC Quality of Life Group website's homepage and will be periodically updated to take into account any new knowledge due to medical, technical, regulatory and scientific advances.

U2 - 10.1016/j.ejca.2016.08.024

DO - 10.1016/j.ejca.2016.08.024

M3 - Review

C2 - 27721057

VL - 68

SP - 73

EP - 81

JO - European Journal of Cancer, Supplement

JF - European Journal of Cancer, Supplement

SN - 0959-8049

ER -

ID: 168214509